phenyl-n-tert-butylnitrone has been researched along with alloxan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bray, TM; Chen, G; Ho, E | 2 |
| Floyd, RA; Kotake, Y; Moore, DR; Tabatabaie, T; Vasquez, AM | 1 |
3 other study(ies) available for phenyl-n-tert-butylnitrone and alloxan
| Article | Year |
|---|---|
Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice.
Topics: Acetylcysteine; Administration, Oral; Alloxan; Animals; Blood Glucose; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Free Radicals; Glutathione; Male; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Pancreas | 1999 |
Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes.
Topics: Alloxan; Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Free Radicals; Hyperglycemia; Islets of Langerhans; Male; Mice; NF-kappa B; Nitrogen Oxides; Reactive Oxygen Species; Spin Labels; Streptozocin | 2000 |
Direct administration of interleukin-1 and interferon-gamma to rat pancreas leads to the in vivo production of nitric oxide and expression of inducible nitric oxide synthase and inducible cyclooxygenase.
Topics: Alloxan; Animals; Cyclic N-Oxides; Cyclooxygenase 2; Gene Expression; Interferon-gamma; Interleukin-1; Islets of Langerhans; Isoenzymes; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Pancreas; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2001 |